Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Preclinical research--toxicology].

H Frohberg

    Arzneimittel-Forschung
    |July 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals.

    Mutation research·1991
    Same author

    Schistosomiasis drugs: an ICPEMC study.

    Progress in clinical and biological research·1990
    Same author

    The toxicological profile of praziquantel in comparison to other anthelminthic drugs.

    Acta Leidensia·1989
    Same author

    Results of toxicological studies on praziquantel.

    Arzneimittel-Forschung·1984
    Same author

    [Pharmacokinetic, pharmacologic and toxicologic properties of praziquantel].

    Salud publica de Mexico·1982
    Same author

    Toxicological profile of praziquantel, a new drug against cestode and schistosome infections, as compared to some other schistosomicides.

    Arzneimittel-Forschung·1981
    Same journal

    Wirksamkeit und Verträglichkeit eines pflanzlichen Arzneimittels mit Kapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentzündung im Vergleich zu anderen Therapien unter den Bedingungen der täglichen Praxis.

    Arzneimittel-Forschung·2013
    Same journal

    Abstracts of the Paul-Martini-Stiftung Symposium 2012 in combination with the National Academy of Leopoldina. November 16-17, 2012. Berlin, Germany.

    Arzneimittel-Forschung·2013
    Same journal

    Leave-one-out procedure in the validation of elimination rate constant analysis.

    Arzneimittel-Forschung·2012
    Same journal

    Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

    Arzneimittel-Forschung·2012
    Same journal

    Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

    Arzneimittel-Forschung·2012
    Same journal

    Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

    Arzneimittel-Forschung·2012
    See all related articles

    Current toxicological testing predicts only 60-70% of drug adverse reactions in humans. Challenges remain in evaluating reproductive, carcinogenicity, and mutagenicity test results for new drug safety.

    Area of Science:

    • Pharmacology
    • Toxicology
    • Drug Development

    Context:

    • Drug development involves rigorous toxicological testing to ensure patient safety.
    • Existing experimental methods have limitations in predicting all adverse drug reactions.
    • Evaluating complex toxicological endpoints like reproductive toxicity, carcinogenicity, and mutagenicity presents significant challenges.

    Purpose:

    • To outline the standard toxicological testing procedures for new pharmaceutical agents.
    • To critically assess the predictive accuracy of current toxicological assays for human adverse drug reactions.
    • To highlight specific difficulties encountered in the interpretation of reproductive-toxicological, carcinogenicity, and mutagenicity data.

    Summary:

    • Toxicological testing protocols for new drugs are described, revealing that current methods can only predict 60-70% of adverse reactions observed in humans.
    Keywords:
    CancerChlormadinone Acetate--side effectsContraceptionContraceptive Agents, Female--side effectsContraceptive Agents, Progestin--side effectsContraceptive Agents--side effectsDiseasesFamily PlanningNeoplasms

    Related Experiment Videos

  • Significant challenges persist in the evaluation of reproductive-toxicological, carcinogenicity, and mutagenicity studies.
  • Illustrative experimental and clinical examples are provided to demonstrate these complex issues in toxicological assessment.

    • Impact:

    • Improved understanding of the limitations in current drug safety evaluation methodologies.
    • Highlights the need for advancements in toxicological testing to enhance prediction of adverse drug reactions.
    • Informs regulatory strategies and future research directions for more comprehensive drug safety assessments.